Glycostem Therapeutics BV   Report issue

For profit Phase 2
Founded: Oss Netherlands (2007)

Organization Overview

First Clinical Trial
2020
NCT04632316
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Glycostem Therapeutics BV